Let's hope so.....a slow grind higher in valuation is always better than a pop in my experience. If a company brings investment dollars with it's story, they tend to stick.
In saying that...the alternative is a monster making a bid, that will appear to be attractive to most holders, but actually steals the company for a fraction of it's future profits.
Right now...I fear a bid by Roche or similar at $1.20-$1.70 that the inexperienced retail shareholders will see as generous, given the 18months share price history, and we will lose all the upside.
Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation, page-32
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.050(8.70%) |
Mkt cap ! $65.94M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 63.0¢ | 57.5¢ | $117.5K | 196.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 2484 | 2 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |